Skip to content

Eugene M. Stoelk, MD

NPI 1487720710ActiveIndividual· Obstetrics & Gynecology, Reproductive Endocrinology· Portland, OR

Obstetrics & Gynecology, Reproductive Endocrinology (MD) in Portland, Oregon, licensed in OR, with an NPI issued in November 2006. Part D covered 11 prescriptions written in 2024. Ferring Pharmaceuticals Inc. was the largest of 2 companies reporting payments in 2025, $72.07 in all, mostly food and beverage.

Overview

NPI1487720710
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedNov 28, 2006
Last updated in NPPESJul 8, 2007

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)11 · 13 30-day fills
Total drug cost$98.67

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$72.07 · 3 payments from 2 companies
  • 2024$93.87 · 4 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Ferring Pharmaceuticals Inc.$46.322
Coopersurgical, Inc.$25.751

What the 2025 payments were for

  • Food and Beverage$72.07 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Obstetrics & Gynecology, Reproductive Endocrinology providers in Portland

All 16 Obstetrics & Gynecology, Reproductive Endocrinology providers in Portland · All Obstetrics & Gynecology, Reproductive Endocrinology providers in Oregon